At 6.3% CAGR, the Acne Treatment Market is Expected to Reach $ 19.03 Billion Globally by 2028, According to Brandessence Market Research

LONDON, January 11, 2022 / PRNewswire / – According to Brandessence Market Research, the size of the acne treatment market has reached $ 12.41 billion in 2021. The acne treatment market is expected to grow at a robust CAGR of 6.3% and reach a size of $ 19.03 billion by the end of 2028.

BEMR logo

This report primarily focuses on the following Acne Treatment companies:


  • Stiefel Laboratories, Inc.

  • Galderma SA

  • Johnson & Johnson Services, Inc.

  • Valeant

  • Teva Pharmaceutical Industries Ltd.

  • GlaxoSmithKline Plc.

  • Roche Holding SA

  • Bayer AG

Get a copy of this Premium Report @

Acne patients represent the eighth largest group of sick patients in the world. Findings published in the Global Burden of Disease Project, created by the University of Washington School of Medicine, also reveal other promising ideas. University results indicate that skin diseases of all types increased disability-adjusted life years (DALYs) by 8% in Canada, during 1990-2017. It also increased the number of years of life adjusted for mortality (YLL) by 4% and the number of years lived with disability (YLD) by 8%. Acne remains a debilitating disease for many, with as many as 50 million people affected in key regions like the United States. In 2013, the American Academy of Dermatology Association estimated that the conditions led to $ 1.2 billion in costs, due to processing and lost productivity. In addition, 5.1 million patients opted for medical treatment for acne in 2013, with the main patients being young adults and children. Growing awareness of the impact of acne on self-esteem, socioeconomic status and life in general remains a key driver of growth globally.

Acne treatment The market report is segmented on the basis of type, treatment modality, end user, drug, therapeutic device, and region and country level.

By type:

  • Cystic acne

  • Inflammatory acne

  • Post-surgical acne / wound

By processing method:

By end user:

By drug:

By therapeutic devices:

  • Lasers

  • Microdermabrader

  • Dermabradors

  • Others

Acne Treatment Market: Impact of Covid-19

Covid-19 has had a negative impact on the growth of the acne treatment market, despite the fact that overall, pharmacies have remained open. Like the treatment of many other diseases, the covid-19 pandemic has delayed treatment, while simultaneously disrupting supplies. The year 2020 saw a resurgence in the growth of the acne treatment market, with non-surgical acne-related treatments like the full-field ablative experiencing tremendous growth. For example, in 2020, the treatment resulted in 225,141 non-surgical procedures worldwide. This figure increased from 190,978 non-surgical procedures worldwide in 2019, marking a promising growth of 17.9%.

Get the methodology @

Acne Treatment Market: Opportunity Analysis

Europe remains the largest market in the global acne treatment market. The region accounted for 76.7 billion euros in sales of cosmetics retail sales in 2020. Countries like Germany, France, UK, Italy, Spain, and Poland remains the biggest contributor to its growth, while Germany leader with 14 billion euros in turnover. Animal testing and the increased demand for natural ingredients pose growing challenges in this region. However, increased funding for research and development promises growing alternatives to animal testing. According to Cosmetics Europe, an industry association, modest estimates put the total R&D funding of European cosmetics manufacturers at 2.35 billion euros in 2017. Large cosmetics companies in the European region spend an average of 5% on R&D , as part of their annual turnover. Growing demand in key regions such as Europe, and the increased interest in R&D to fuel the launch of new cosmetic products remain promising growth engines in the acne treatment market.

Acne Treatment Market: Notable Development

Sanofi, one of the world’s leading vaccine manufacturers, has acquired Origimm Biotechnology, a company specializing in skin diseases, in december 2021. The acquisition is a significant development in the acne treatment market as it could introduce vaccine-based acne treatment to the current repertoire of established treatments. The acquisition agreement is expected to provide Sanofi with the license rights to ORI-001, a therapeutic vaccine to treat acne vulgaris. The recombinant protein-based vaccine entered the primary clinical study in the third quarter of 2021. Sanofi is expected to leverage its own messenger RNA platform to prepare the vaccine for further testing, ahead of final approval.

The Special Requirements Acne Treatment Market report is also available for the region below:

North America


  • Germany, France, United Kingdom, Italy, Spain, Sweden, Netherlands, Turkey, Switzerland, Belgium, Rest of Europe

Asia Pacific

  • South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, rest of APAC,

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, United Arab Emirates, Egypt, South Africa, Rest of MEA

Get full access to all reports:

Associated reports:

i-Factor: live market intelligence platform

I-Factor is our guaranteed seal to keep our clients always ahead of the competition. This knowledge platform provides real-time updates on key economic indicators, competitive landscape, changing demand, trends, personalized regional information, and more. The platform visualizes key data points to help make decision making agile, trustworthy and holistic. Sign up for a free trial here @

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports and business information produced by highly trained and experienced industry analysts. Our research reports are available across a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, construction, chemicals and more. The Brand Essence Market Research report will be best suited for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs and directors, governments, agencies, organizations and doctors. Students. We have a delivery center in Pune, India and our sales office is in London.


Blog: Radiopharmaceutical companies

Follow us: LinkedIn

Mr. Vishal Sawant
[email protected]
E-mail: [email protected]
Sales to businesses: + 44-2038074155
Asia office: +917447409162



View original content: – -says-brandessence-market-research-301458240.html

SOURCE Brandessence Market Research And Consulting Private Limited

About Antoine L. Cassell

Check Also

IMU-838 treatment associated with low rate of confirmed disability worsening in relapsing MS

Recently reported interim data from the Phase 2 EMPhASIS trial (NCT03846219) of Immunic’s investigational agent, …

Leave a Reply

Your email address will not be published.